NCT06641752

Brief Summary

The main goal of COCAP is to compare COHb (carboxyhemoglobin) levels measured from venous or arterial samples with those measured from capillary samples in patients suspected of Carbon Monoxide intoxication.Patient participation in the study will be limited to capillary sampling (approx. 5-15 minutes).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started Feb 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Feb 2025Feb 2027

First Submitted

Initial submission to the registry

October 10, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

February 5, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2027

Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

October 10, 2024

Last Update Submit

December 2, 2025

Conditions

Keywords

IntoxicationCarbon monoxydeCarboxyhemoglobinCOHbCarboxyhemoglobin capillary

Outcome Measures

Primary Outcomes (1)

  • Determine the accuracy of capillary HbCO measurement (compared with venous or arterial HbCO) in patients with suspected CO poisoning.

    The main goal will be determined by the mean bias and limits of agreement between capillary and venous (or arterial) sampling (Bland-Altman analysis).

    15 minutes

Secondary Outcomes (5)

  • Determine the diagnostic performance of capillary measurement

    15 minutes

  • Assess the technical difficulties of different blood sampling processes (Measurement of the number of attempts and failure rate for samples)

    15 minutes

  • Assess the technical difficulties of different blood sampling processes (Measurement of the time required to take each sample)

    15 minutes

  • Analyse the technical difficulties associated with the analysis of the two samples (Time between sampling and HbCO result)

    15 minutes

  • Analyse the technical difficulties associated with the analysis of the two samples (percentage of samples that cannot be analysed by the laboratory)

    15 minutes

Study Arms (1)

Study population

The study population must correspond to the research inclusion criteria: Adult patient admitted to the emergency department, presenting with one or more clinical signs (asthenia, headache, nausea, vomiting, loss of consciousness, etc.) and a history compatible with CO intoxication (collective symptoms, notion of smoke, activation of a detector, etc.)

Diagnostic Test: Blood drop sampling

Interventions

Blood drop samplingDIAGNOSTIC_TEST

The process: blood drop sampling Technique: capillary sampling Frequency: Once Time: 5 minutes Sample collection volume: 1mL Total collection volume: 1 mL

Study population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will consist of patients admitted to adult emergency departments with suspected carbon monoxide intoxication.

You may qualify if:

  • Adult patient admitted to emergency department
  • Presenting one or more clinical signs (asthenia, headache, nausea, vomiting, loss of consciousness, etc.) and a history compatible with CO intoxication (collective symptoms, notion of smoke, activation of a detector, etc.).

You may not qualify if:

  • Minors
  • Patients under protective supervision (safeguard of justice, curatorship, guardianship)
  • Incarcerated patients
  • Pregnant or breast-feeding women
  • Patients refusing to take part in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU d'Angers

Angers, Loire-Atlantique, 49100, France

RECRUITING

Nantes University Hospital

Nantes, Loire-Atlantique, 44000, France

RECRUITING

MeSH Terms

Conditions

Carbon Monoxide Poisoning

Condition Hierarchy (Ancestors)

Gas PoisoningPoisoningChemically-Induced Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2024

First Posted

October 15, 2024

Study Start

February 5, 2025

Primary Completion (Estimated)

February 5, 2027

Study Completion (Estimated)

February 5, 2027

Last Updated

December 9, 2025

Record last verified: 2025-12

Locations